Administration of protein hydrolysates from anchovy (Engraulis encrasicolus) waste for twelve weeks decreases metabolic dysfunction‐associated fatty liver disease severity in ApoE–/–mice
Metabolic dysfunction‐associated fatty liver disease (MAFLD) includes several diseases, ranging from simple steatosis to steatohepatitis, fibrosis and cirrhosis. Fish‐rich diets are considered helpful in the prevention of MAFLD, and the enzymatic hydrolysis of fish waste has been explored as a means of obtaining high‐value protein hydrolysates, which have been proven to exert beneficial bioactivities including anti‐obesity and hypocholesterol effects.